Trial Design and Setting
stroke
STROKE, MAY
This investigator-led, randomized, open-label, blinded end-point, 2 × 2 factorial trial was conducted at 26 stroke specialist hospitals in the UK. We randomized patients between February 5, 2018, and May 31, 2021. The trial was registered with ISRCTN (